Eye Dryness Evaluation in Primary Sjögren's Syndrome
PEPSS
Pateint-reported Outcomes and Objective Eye Dryness Evaluation in Primary Sjögren's Syndrome.
1 other identifier
observational
45
1 country
1
Brief Summary
The objective of this observational study is to develop new tools to assess primary Sjögren's syndrome (pSS) symptoms and to measure the severity of eye involvement in these patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Nov 2019
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 31, 2018
CompletedFirst Posted
Study publicly available on registry
August 3, 2018
CompletedStudy Start
First participant enrolled
November 20, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 28, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
August 28, 2020
CompletedFebruary 5, 2025
February 1, 2025
9 months
July 31, 2018
February 3, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Variability in the intensity of patient-reported symptoms
Variability over time (day-to-day assessment) of the ESSPRI score (dispersion of the values compared to the mean)
3 months
Secondary Outcomes (3)
Tolerability of the daily use of a webapp to measure the symptoms
Month 3
Interferometry
3 months
Automated eye surface coloration measurement
3 months
Study Arms (1)
pSS cohort
Patients with pSS included in the study
Interventions
A webapp will be installed on the patients' smartphone, which will be used to collect everyday the symptoms of the patients (ESSPRI score)
Evaluation of the mebomian function using the LipiView methodology
Eligibility Criteria
Consecutive pSS patients seen in Rheumatology
You may qualify if:
- diagnosis of pSS according to ACR/EULAR classification criteria
You may not qualify if:
- patient does not possess a smartphone with web connection
- patient unable to sign an informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU de BREST
Brest, 29200, France
Biospecimen
Serum, saliva, cells
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 31, 2018
First Posted
August 3, 2018
Study Start
November 20, 2019
Primary Completion
August 28, 2020
Study Completion
August 28, 2020
Last Updated
February 5, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- Data will be available beginning after publication of result and ending three years maximum following the last visit of last patient
- Access Criteria
- Data access requests will be reviewed by the internal committee of Brest UH. Requestors will be required to sign and complete a data access agreement.
All collected data that underlie results in a publication